Biocept Inc, an emerging leader in genetic testing has developed novel technology for rare cell isolation and specimen purification. The company’s proprietary CEET Cell Enrichment and Extraction technology is designed to recover rare cells from body fluids. The CEE process enables early, accurate genetic analysis of rare cells and is used exclusively in Biocept Laboratories’ first product, preCEEdT prenatal diagnostic. preCEEd is the only first-trimester prenatal diagnostic to look directly at fetal cells, eliminating the risks of invasive procedures such as amniocentesis and CVS. This in-house-developed test is performed in Biocept’s CLIA certified laboratory. Future applications of the CEE technology will include oncology and immunology.
Biocept Inc, an emerging leader in genetic testing has developed novel technology for rare cell isolation and specimen purification.